10 Reasons to Buy Veeva Systems Inc. Stock and Never Sell
A little over a decade ago, Peter Gassner was an executive at salesforce.com (NYSE: CRM). While he was out pushing the company's cloud services, he noticed something: The pharmaceutical industry had very specific needs that salesforce.com couldn't easily meet.
Taking that information, he left salesforce.com to found Veeva Systems (NYSE: VEEV), where he still functions as the company's CEO. He started his work with Veeva CRM, a customer relationship management tool for Big Pharma. Then he really hit it out of the park with Veeva Vault, a product that helps companies manage -- in the simplest sense -- all of the data that they need to track to obtain FDA approval for their drugs.
Image source: Getty Images
Source: Fool.com
Salesforce.com Stock
€264.30
3.360%
The stock is an absolute favorite of our community with 62 Buy predictions and no Sell predictions.
As a result the target price of 275 € shows a slightly positive potential of 4.05% compared to the current price of 264.3 € for Salesforce.com.
